NREU, BESMIR
 Distribuzione geografica
Continente #
NA - Nord America 929
EU - Europa 345
AS - Asia 153
AF - Africa 1
Totale 1.428
Nazione #
US - Stati Uniti d'America 923
IE - Irlanda 113
IT - Italia 74
RU - Federazione Russa 71
SE - Svezia 62
CN - Cina 57
HK - Hong Kong 50
SG - Singapore 22
JO - Giordania 21
CA - Canada 6
UA - Ucraina 6
DE - Germania 5
ES - Italia 4
FI - Finlandia 4
GB - Regno Unito 4
JP - Giappone 2
LU - Lussemburgo 1
NL - Olanda 1
SC - Seychelles 1
TR - Turchia 1
Totale 1.428
Città #
Fairfield 168
Dublin 112
Woodbridge 75
Ashburn 73
Cambridge 73
Seattle 70
Houston 57
Chandler 54
Wilmington 54
Moscow 40
Lawrence 39
Altamura 34
Beijing 32
Hong Kong 30
Princeton 29
Ann Arbor 24
Boston 20
Florence 19
Singapore 16
San Diego 14
Medford 9
Shanghai 9
Kent 8
Boardman 7
Redwood City 7
Andover 6
Toronto 6
Hillsboro 5
Barcelona 4
Falls Church 4
Menlo Park 4
Redmond 4
Bari 3
Buffalo 3
Norwalk 3
Novara 3
Guangzhou 2
Los Angeles 2
Maiori 2
New York 2
Rui'an 2
Atlanta 1
Cento 1
Esslingen am Neckar 1
Falkenstein 1
Forest City 1
Helsinki 1
Hounslow 1
Jinan 1
Kilburn 1
Laurel 1
London 1
Mahé 1
Messina 1
Miami 1
Nanjing 1
Nantong 1
Quanzhou 1
Rome 1
Trumbull 1
Winchester 1
Wuhan 1
Totale 1.149
Nome #
Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials 87
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 83
Is early measurement of glycated albumin and HbA1c useful for the prediction of treatment response in type 2 diabetes? 78
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials 72
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials 71
CO2 laser for the treatment of diabetic foot ulcers with exposed bone. A consecutive series of type 2 diabetic patients 67
Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials 67
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials 67
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials 66
Effects of SGLT-2 inhibitors on diabetic ketoacidosis: A meta-analysis of randomised controlled trials 61
Short and medium-term efficacy of sodium glucose co-transporter-2 (SGLT-2) inhibitors: a meta-analysis of randomized clinical trials 61
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials 57
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials 52
Cholelithiasis in patientes treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials 50
Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials 48
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 47
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials 46
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials 46
Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy 45
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials 42
Major Amputation In Non-Healing Ulcers: Outcomes and Economic Issues. Data from a Cohort of Patients with Diabetic Foot Ulcers 39
Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials 35
Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 32
Rate and predictors of hesitancy toward sars-cov-2 vaccine among type 2 diabetic patients: Results from an italian survey 29
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials 27
COVID-19 Vaccine Hesitancy and Early Adverse Events Reported in a Cohort of 7,881 Italian Physicians 27
Effects of insulin on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials 22
Covid-19 pandemic, diabetes and glycemic control: Results of a retrospective cohort study of 230.000 persons with diabetes in tuscany 17
Trust of Italian healthcare professionals in covid-19 (anti-sars-cov-2) vaccination 16
LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias 9
Totale 1.466
Categoria #
all - tutte 6.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.231


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020289 0 12 7 18 34 36 34 38 31 33 28 18
2020/2021180 13 18 4 18 7 23 12 13 25 19 14 14
2021/2022173 9 17 9 16 7 7 6 18 2 12 12 58
2022/2023440 66 98 35 13 13 69 67 8 45 6 17 3
2023/2024178 8 20 28 5 6 8 8 43 8 26 15 3
2024/202570 37 33 0 0 0 0 0 0 0 0 0 0
Totale 1.466